Azathioprine is More Effective than Mesalazine at Preventing Recurrent Bowel Obstruction in Patients with Ileocecal Crohn’s Disease

BACKGROUND: Patients with subocclusive Crohn’s disease (CD) who received azathioprine (AZA) therapy had lower re-hospitalization rates due to all causes and for surgical management of CD compared to those treated with mesalazine during a 3-year period. We investigated whether AZA also was effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidigal, Fernando Mendonça, de Souza, Gláucio Silva, Chebli, Liliana Andrade, da Rocha Ribeiro, Tarsila Campanha, Furtado, Maria Cristina Vasconcellos, Castro, Antonio Carlos Santana, Pinto, André Luis Tavares, do Valle Pinheiro, Bruno, de Lima Pace, Fabio Heleno, de Oliveira, Juliano Machado, de Oliveira Zanini, Karine Andrade, Gaburri, Pedro Duarte, Zanini, Alexandre, Ribeiro, Luiz Cláudio, Chebli, Julio Maria Fonseca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301229/
https://www.ncbi.nlm.nih.gov/pubmed/25370731
http://dx.doi.org/10.12659/MSM.890975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301229/
https://www.ncbi.nlm.nih.gov/pubmed/25370731
http://dx.doi.org/10.12659/MSM.890975

Ejemplares similares